Division of Endocrinology
and Metabolism:
FINCH UNIVERSITY/ CHICAGO MEDICAL SCHOOL
2003/2003
Chief & Program Director Sant P. Singh, MD
Swedish Covenant Hospital, Chicago
Site Director: Frederick Ellyin MD
Pediatric Endocrine training
University of Illinois at Chicago
Site Director: Sonia Pang, MD
Gynecologic Endocrine training
St. Joseph Hospital, Chicago
Site Director: A. Hosseinian, MD
DIVISION FACULTY
Sant P Singh, MD Professor of Medicine, Professor of Physiology & Chief,
Division of Endocrinology-Diabetes-Metabolism
Srinivas Achar, PhD Adjunct Assistant Professor of Medicine
Charles P. Barsano, MD, PhD Associate Dean of Clinical Affairs Professor of Medicine, Pharmacology & Molecular Biology
Sidney Cruz, MD Chairman, Department of Medicine and Chief of Endocrinology, Swedish Covenant Hospital, Assistant Professor of Clinical Medicine
Lawrence Domont, MD Clinical Associate and Professor of Medicine
William F. Eckhardt, Jr., MD Lecturer of Medicine
Fredrick Ellyin, MD Associate Dean of Education, Professor of Clinical Medicine
& Family Medicine, FUHS/CMS; Program Director, Endocrinology and Vice
Chairman, Department of Medicine, Swedish Covenant Hospital
Janice L. Gilden, MD Professor of Medicine
Raj K. Handa, PhD Research Assistant Professor
Yoginder Kumar, MD Assistant Professor of Medicine
Menahem Lender, MD Clinical Associate, Professor of Medicine
Lawrence Perlmutter, PhD Professor of Medicine, Professor of Psychology
Gordon Pullen, PhD Adjunct Assistant Professor of Medicine
Charles E. Rhodes, MD Lecturer of Medicine
Ann K. Snyder, PhD Research Associate Professor of Medicine and Associate Professor of Pharmacology
Y. Yoon, MD, PhD Professor of Microbiology, Immunology and Medicine
M. Kyncyl, MD Clinical Assistant Professor
Of Medicine
Janine Stoll, RN, C.D.E. Diabetes Nurse Specialist
ENDOCRINE FELLOWSHIP COMMITTEE
I. PURPOSE
To establish membership, responsibility and functions of the Endocrine-Diabetes-Metabolic Fellowship Committee.
II. POLICY
To provide coordinated training to the Fellows and Residents/Students elective
programs.
III. MEMBERSHIP
Sant P. Singh, MD, Chairperson
Charles P. Barsano,MD, PhD
Sandra Dempsey, MD
Janice L. Gilden, MD
Janine Stoll, RN, C.D.E.
Jayshree Dhali, MD (Fellow Representative)
EDUCATION
TRAINING SITES:
North Chicago Veterans Affairs Medical Center;
St. Joseph's Hospital, Chicago;
Swedish Covenant Medical Center, Chicago;
University of Illinois Medical Center, Chicago
TEACHING CORE CONFERENCES:
CONFERENCE SITE SCHEDULE
1. Clinical Endocrine
Conference VA/CMS 7/Month
2. Journal Club VA/CMS 3/Month
3. Research
Conference VA/CMS 1/Month
4. Medical Grand
Rounds CMS 4/Month
TEACHING CORE CONFERENCES (Cont'd):
CONFERENCE SITE SCHEDULE
5. Diabetes Team
Meeting VA 1/every 2 Mos
5. Review Endocrine
Topics VA/SCH 4/Month
6. **Endocrine UIC 1/Week
Pediatric/ (During rotation)
7. RN & RD education VAMC/NC 1/Month
sessions with fellows
**During rotation, exact location, Dates and Times are published separately.
ADDITIONAL CONFERENCES/COURSES:
1. Basic Science Endocrine Seminars (A.K. Snyder, PhD)
2. Monthly Diabetes team meeting.
3. Endocrine-related renal disease seminars. Dr. J. Cheng, Professor of Medicine, offers a course for EDM residents to discuss various topics included in the endocrine curriculum. The course is repeated each year.
4. National Scientific Conferences. The EDM residents attend national endocrine conferences or courses. Each resident attends 2-3 such program each year. Endocrine Fellowship foundation is helpful in this regard. Each year different meetings are available. The following are some representative examples:
Annual Meetings of American Diabetes Association;
Annual meeting of American Thyroid Association;
American Federation of Medical Research, Midwestern Section Meeting;
American Diabetes Association, 49th Annual Advance Post -Graduate Course;
The Endocrine Society Osteoporosis: Prevention, Detection
and Treatment;
American College of Endocrinology, Mayo Foundation; Technology for Endocrinology
Fellows in Training;
Various endocrine symposia held in Chicago area.
FELLOWS AND OTHER TRAINEES
Fellows: Boby G. Theckedath, MD
Jayshree Dhali, MD
Ramona Pungan, MD
Students and Residents (July 1, 2002 - June 30, 2003):
Katherine Pearce MS-4 7/1/02-8/3/02
Taye Hattisburg PGY-2 7/3/02-8/3/02
Baig Mirza PGY-2 8/2/02-8/31/02
Diana Tracy PGY-1 Psych 9/27/02-10/30/02
Nilanben Shah PGY-3 10/3/02-11/2/02
Sreejaya Veluvali PGY-1 Psych 11/4/02-12/2/02
Inna Factourovich PGY-1 Psych 11/4/02-12/2/02
Brian Midkiff MS-4 02/17/03-3/14/03
Fabio Urresta PGY-1 Psych 03/31/03-04/30/03
Ajit Narb MS-4 03/31/03-04/27/03
Minerva Galang PGY-3 04/03/03-04/30/03
Joana Taeke PA student 04/14/03-04/18/03
Wendy Frederick PA student 04/14/03-04/18/03
Hvy Nguyen MS-4 04/28/03-05/23/03
RESEARCH AND OTHER SCHOLARLY ACTIVITIES
Facilities. Basic science and clinical research laboratories are located at the various sites of the training program at the Finch University of Health Sciences/The Chicago Medical School. The following are major research areas of interest to the faculty:
Sant P. Singh, MD
Basic and clinical research including glucose transporters, glucose metabolism, hypertension, metabolic effects of alcoholism and pharmacology of anti-diabetic drugs.
Janice L. Gilden, MD
Orthostatic hypotension, catecholamines, and quality of life studies in diabetes.
Charles P. Barsano, MD, PhD
Thyroid hormone receptors distribution; thyroid drugs pharmacology and teaching methods.
Fredrick Ellyin, MD
Clinical research program related to androgens, aging and osteoporosis.
Ann Snyder, PhD
Molecular Biology of Alcoholism and Pharmacology.
Sidney Cruz, MD
Wound Healing.
Srinivasa Achar, PhD
Endocrine Biochemsity of Glucose Metabolism.
Raj K. Handa, Ph.D.
Molecular Biology of Glucose Transport.
RESEARCH GRANTS
1. Mechanism of Abnormal Glucose Transport in Alzheimer's Disease.
2001-2002
Illinois Dept of Public Health $20,200
2. Glucocorticoid Induced Osteoporosis in Men: A retrospective study.
2000-2002
Merck & Co. $10,000
3. Insulin Lispro how mixture plus Metformin compared to NPH Insulin Plus
Metformin in subjects with Type 2 Diabetes with Inadequate Glycemic Control
on Oral Therapy. (Lispro-OIMN Study). J. Gilden (PI), S. Singh (Co-I)
2002
Eli Lilly $54,000
4. Randomized Double-Blind, Multicenter Study to Define clinical Benefit of
Midodrine HCL in Patients with Neurogenic Orthostatic Hypotension (Midodrine
#401).
J. Gilden, (PI)
December 1997-Present
Shire/Roberts Pharmaceuticals $140,000
5. Topiramate vs. Placebo in the Relief of Pain in Diabetic
Peripheral Neuropathy and Long Term Extension Study
(TOPMAT-NP) with addendum for neurophysiological testing.
J.L. Gilden, (PI)
Feb. 2000 to Nov. 2002
Johnson Pharmaceutical
Research Institute Trial $57,481
6. LY33531 Treatment for Symptomatic Peripheral Neuropathy
in patients with Diabetes
2003-2005
Eli- Lilly $114,000
7. LY33531 Treatment of Peripheral Neuropathy in patients with Diabetes
2003-2006
Eli- Lilly $168,000
8. Molecular Regulation of Brain Glucose Uptake in Alzheimer's Disease
2003-2006
Dept. of Veterans Affairs $356,100
(To be resubmitted)
9. Beta Cell Replacement Therapy for Type 1 Diabetes (CO-PI)
(Pending)
NIH $765,000
PUBLICATIONS
1. Rudy DR, Singh S, Barsano CP, and Baba WI: "Endocrinology" (Chapter: CP Barsano Section on Thyroid Disease). In: Textbook of Family Practice [RE Rakel, ed.], 6th Edition, Sauders, NY, pp 1044-1061, 2002.
2. The ALLHAT Research Group: Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic. JAMA 2002:, 288-2981
3. Madariaga M, Gamarra N, Dempsey S, and Barsano C. Polymyositis-Like Syndrome in Hypothyroidism: Review of Cases Reported Over the Past Twenty-five Years. Thyroid 12:331-336, 2002. (Note: because of an administrative error, Dr. Madariaga is the only author cited in the journal article).
4. The Allhat Research Group: Major Outcomes in Moderately Hypercholesterolemic, Hypertensive Patients Randomized to Pravastatin vs Usual Care. JAMA 2002; 228:2998-3007.
5. Gilden,JL: (Invited Chapter)"Midodrine and Sympathomimetics", in The Primer of Autonomic Disorders, Robertson,DL, Low PA, and Biagionni,I (Editors) (in press)
6. Kim SH, Callaci JJ, Ehmann S, Singh SP, Snyder AK. Ethanol Inhibits Glucose
Transporter Expression and Pentose Phosphate Pathway Activity in Cultured
Glial Cells. Alcoholism EXP CLIN Res 2003.
7. Handa, RK, Singh LDTB, Singh SP. Effect of Handa RK, Singh LDTB, Singh
SP. Effect of Ethanol on Glucose Transporter by L6 Cells. Hormone Metabolic
Research (Submitted) 2003.
8. Dhali, Jayshree, Dempsey, S, Chedid, A, and Barsano, C. Pituitary Macroadenoma.
Endocrine Practice (in preparation).2003
9. Pungan, R, Stoll, J, and Singh, S. P. Continuous Glucose Monitoring in
Type 2 Diabetes. Endocrine Practice (in preparation). 2003
ABSTRACTS
1. Akbar A, Gilden JL, Dempsey S, and Singh SP: Pancreatic Malignant APUDOMA
Manifesting with hyperglycemia followed by hypoglycemia. Am Assoc Clin Endo
annual mtg, Atlanta, GA, 2002.
2. Gilden JL, Saegh M, Ramierez D, Tartakover A, Wahidi G, and
Garcia I: Symptoms of Autonomic Dysfunction in Patients
With Neurogenic Orthostatic Hypotension Compared to Other Chronic Diseases.
Clinical Autonomic Research 2002. Vol 4, 324.
3. Gilden JL, Ramirez DY, Tartakover A, and Garcia I. A Comparison of Hemodynamic Responses in Diabetic Patients with other Etiologies of Neurogenic Orthostatic Hypotension. Diabetes 2002, Supplement, A520.
4. Handa RK, Theckedath B, Singh SP: Up-regulation of glucose transporter-1
(GLUT-1) mRNA by beta-Amyloid in Cultured Normal Human Astrocytes (Abstract).
85th Ann Mtg Endo Soc, Philadelphia,PA, June 19-22, 2003 Endo Society Program
2003.
5. McGee,BK, Stoll,J, Pungan,R, Perlmutter,LC, Singh,SP: Self initiated recreational
activities improved glycemic control in males with type 2 diabetes. Am Diabetes
Assoc.Annual Mtg New-Orleans,LA 2003
6. Perlmutter LC, McGee BK, Pungan R, Stoll J, Singh SP: Duration and Family
History of Diabetes Predicts Depression and Hopelessness in Male Type 2 Diabetic
Patients (Abstract). 18th International Diabetes Federation Congress, Paris,
France 24-29 Aug, 2003.
7. Singh SP, Handa RJ, Theckedath B: Glucose Transport and Glucose Transporter1
(GLUT1) Expression in Human Astrocytes: Studies in Relation to Alzheimer's
Disease (Abstract). 18th International Diabetes Federation Congress, Paris,
France 24-29 Aug, 2003.
8. Vattikuti R, Gammara N, Weberski J, Gall EP, Singh SP: Bone Mineral Density
in Glucocortocoid Treated Obstructive Lung Disease in Comparsion to Rheumatoid
Arthritis and Other Patients. Endocrine Soc Annual Mtg, June 16, 2002, San
Francisco, CA: 2002.
FACULTY HONORS AND RECOGNITION
Cited in Cassells for Top Endocrinologists in the Chicagoland area 2002. (J.
L. Gilden, MD)
Saint Mary of Nazareth Hospital Center-Citizen of the Year Award in Medicine
(J. L. Gilden, MD)
Board of Directors, American Association for Autonomic Nervous System Disorders.
(J. L. Gilden, MD)
Journal Reviewer for "Diabetes Care', American Journal of Kidney Disorders:
"Diabetic Medicine: "Drugs and Aging" and "Clinical Autonomic
Research", Endocrine, (J. L. Gilden, MD)
Diabetes Coalition for Communities of Color (member 1995-present) (J. L. Gilden,
MD)
DIVISION ASSESSMENT
1. Fellowship training program is fully accredited without any stipulation until 2005.
2. Endocrine-diabetes-metabolic division teaching staff is limited. It has continued to pursue patient care, education and research despite heavy load on the faculty to fulfill administrative duties.
3. The goal and objectives for the coming year include expanded academic activities at the affiliated institutions and within FUHS/CMS.
4. Needs and Requirements.
(a) To add teaching faculty as the current active teaching staff have multiple other obligations which can affect the training program.
(b) To rectify current situation of 3 fellows vice 4 by procuring an additional training slot at the affiliated hospitals or developing an additional training site for at least one training slot.